|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/43 | (2006.01) |
| A61K 38/43 | (2013.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 13/12 | (2006.01) |
| (11) | Number of the document | 3762018 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19721159.2 |
| Date of filing the European patent application | 2019-03-08 | |
| (97) | Date of publication of the European application | 2021-01-13 |
| (45) | Date of publication and mention of the grant of the patent | 2024-02-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/NL2019/050153 |
| Date | 2019-03-08 |
| (87) | Number | WO 2019/172766 |
| Date | 2019-09-12 |
| (30) | Number | Date | Country code |
| 201862640494 P | 2018-03-08 | US |
| (72) |
PICKKERS, Roelof Peter , NL
MEHTA, Ravindra Lall , NL
MURRAY, Patrick Thomas , NL
JOANNIDIS, Michael , NL
VAN DEN BERG, Erik Jan , NL
AREND, Jacques Salomon Robert , NL
|
| (73) |
AM-Pharma B.V. ,
Stadsplateau 7, 3521 AZ Utrecht,
NL
|
| (54) | RECOMBINANT ALKALINE PHOSPHATASE FOR USE IN TREATING SEPSIS-ASSOCIATED ACUTE KIDNEY INJURY |
| RECOMBINANT ALKALINE PHOSPHATASE FOR USE IN TREATING SEPSIS-ASSOCIATED ACUTE KIDNEY INJURY |